Hype
Trump Administration Ends Medicare Drug Subsidy Program
2026-07-30 · 2 sources · 75% confidence
+35 HYPE
IF YOU ONLY DO ONE THING
Monitor whether this policy change is reversed through normal legislative/regulatory processes, or whether it becomes part of a broader pattern of Medicare/Medicaid dismantling that would elevate constitutional concern.
Why This Score
This is a standard policy change affecting healthcare costs, not constitutional governance. While it impacts vulnerable populations (civil_rights driver scored 1/5 for unequal burden on seniors), it operates through normal executive authority over Medicare programs. The B-score is elevated due to high media-friendliness (seniors + drug costs = easy coverage), outrage potential, and volume-to-substance mismatch, but lacks strong intentional distraction timing.
Damage Score Drivers
Election Integrity & Transfer of Power×0.22
0.0/5
Rule of Law / Due Process×0.18
0.0/5
Separation of Powers×0.16
0.0/5
Civil Rights / Equal Protection×0.14
1.0/5
Institutional Capture×0.14
0.0/5
Corruption / Self-Dealing×0.1
0.0/5
Violence / Intimidation Enabling×0.06
0.0/5
Sev: durability=1 · reversibility=1 · precedent=0.8 · mech=1.05× scope=1.1×
Hype Score: Layer 1 — Hype (55%)
Outrage-bait
3.0/5
Meme-ability
2.0/5
Novelty Spike
2.0/5
Media Friendliness
4.0/5
Layer 2 — Strategic (45%)
Media-Volume Mismatch
3.0/5
Timing Overlap
0.0/5
Narrative Pivot
1.0/5
Repeat Pattern Match
2.0/5
Intentionality: 4/15 → Reduced (0.25)
Covering For
Trump Executive Order Restricting Mail-In Voting - Supreme Court Appeal
SI: 32.1 🟡 · Displacement: MED